Diamond Sante Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-07-2024
- Paid Up Capital ₹ 0.70 M
as on 04-07-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 2.00 M
as on 04-07-2024
- Revenue -93.20%
(FY 2020)
- Profit -2050.37%
(FY 2020)
- Ebitda -2677.30%
(FY 2020)
- Net Worth -37.63%
(FY 2020)
- Total Assets -25.23%
(FY 2020)
About Diamond Sante Therapeutics
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹2.00 M.
Joy Varuthunny, Shankar Ramkrashanan, Vellalathkamalam Menon, and Five other members serve as directors at the Company.
- CIN/LLPIN
U74999KL2014PTC036947
- Company No.
036947
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jul 2014
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Palakkad, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Diamond Sante Therapeutics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Haridas Pullanoor  | Managing Director | 23-Jul-2014 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Joy Varuthunny | Director | 24-Jan-2019 | Current |
| Shankar Ramkrashanan | Director | 23-Jul-2014 | Current |
| Vellalathkamalam Menon | Director | 23-Jul-2014 | Current |
| Mohammed Ali | Director | 23-Jul-2014 | Current |
| Thelakkat Manoj | Director | 23-Jul-2014 | Current |
| Ponneth Anoop | Director | 23-Jul-2014 | Current |
Financial Performance of Diamond Sante Therapeutics.
Diamond Sante Therapeutics Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 93.2% decrease. The company also saw a substantial fall in profitability, with a 2050.37% decrease in profit. The company's net worth observed a substantial decline by a decrease of 37.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diamond Sante Therapeutics?
In 2018, Diamond Sante Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Healia Pharmaceuticals Private LimitedActive 5 years 11 monthsJoy Varuthunny, Shankar Ramkrashanan and 3 more are mutual person
- Ashrayam Pharmaceutical Distributors Private LimitedActive 16 years 9 months
Mohammed Ali is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 14 Jan 2016 | ₹2.00 M | Open |
How Many Employees Work at Diamond Sante Therapeutics?
Unlock and access historical data on people associated with Diamond Sante Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diamond Sante Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diamond Sante Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
